Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Apr 21;288(6425):1180–1181. doi: 10.1136/bmj.288.6425.1180

Wilson's disease.

D Parkes
PMCID: PMC1441309  PMID: 6424779

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brewer G. J., Hill G. M., Prasad A. S., Cossack Z. T., Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med. 1983 Sep;99(3):314–319. doi: 10.7326/0003-4819-99-3-314. [DOI] [PubMed] [Google Scholar]
  2. Carpenter T. O., Carnes D. L., Jr, Anast C. S. Hypoparathyroidism in Wilson's disease. N Engl J Med. 1983 Oct 13;309(15):873–877. doi: 10.1056/NEJM198310133091501. [DOI] [PubMed] [Google Scholar]
  3. Cartwright G. E. Diagnosis of treatable Wilson's disease. N Engl J Med. 1978 Jun 15;298(24):1347–1350. doi: 10.1056/NEJM197806152982406. [DOI] [PubMed] [Google Scholar]
  4. Chan W. Y., Cushing W., Coffman M. A., Rennert O. M. Genetic expression of Wilson's disease in cell culture: a diagnostic marker. Science. 1980 Apr 18;208(4441):299–300. doi: 10.1126/science.7367859. [DOI] [PubMed] [Google Scholar]
  5. LaRusso N. F., Summerskill W. H., McCall J. T. Abnormalities of chemical tests for copper metabolism in chronic active liver disease: differentiation from Wilson's disease. Gastroenterology. 1976 May;70(5 PT1):653–655. [PubMed] [Google Scholar]
  6. SCHEINBERG I. H., GITLIN D. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). Science. 1952 Oct 31;116(3018):484–485. doi: 10.1126/science.116.3018.484. [DOI] [PubMed] [Google Scholar]
  7. Saito T. An assessment of efficiency in potential screening for Wilson's disease. J Epidemiol Community Health. 1981 Dec;35(4):274–280. doi: 10.1136/jech.35.4.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Scheinberg I. H. Investigating diseases no one's got. N Engl J Med. 1983 Oct 13;309(15):918–919. doi: 10.1056/NEJM198310133091509. [DOI] [PubMed] [Google Scholar]
  9. Scheinberg I. H. Penicillamine in Wilson's disease. Lancet. 1982 Jun 26;1(8287):1469–1469. doi: 10.1016/s0140-6736(82)92478-3. [DOI] [PubMed] [Google Scholar]
  10. Sternlieb I. Diagnosis of Wilson's disease. Gastroenterology. 1978 Apr;74(4):787–789. [PubMed] [Google Scholar]
  11. Su L. C., Ravanshad S., Owen C. A., Jr, McCall J. T., Zollman P. E., Hardy R. M. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans. Am J Physiol. 1982 Sep;243(3):G226–G230. doi: 10.1152/ajpgi.1982.243.3.G226. [DOI] [PubMed] [Google Scholar]
  12. WALSHE J. M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487–495. doi: 10.1016/0002-9343(56)90066-3. [DOI] [PubMed] [Google Scholar]
  13. Walshe J. M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet. 1982 Mar 20;1(8273):643–647. doi: 10.1016/s0140-6736(82)92201-2. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES